Clinical trial

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity…

NCT00183391 · Icahn School of Medicine at Mount Sinai, Other · Completed

Key facts

NCT number NCT00183391
Title Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
Official title Measuring and Predicting Response to Atomoxetine and Methylphenidate
Lead sponsor Icahn School of Medicine at Mount Sinai, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions Attention Deficit Disorder With Hyperactivity
Intervention type Drug
Interventions Atomoxetine, Methylphenidate
Enrollment 232
Start date Jul 1, 2005
Primary completion Jun 1, 2011
Completion Jun 1, 2011
First posted Sep 16, 2005
Last update posted Jun 6, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies